Anaerobe Identification by Sequencing (Bill Only)
Use
The Anaerobe Identification by Sequencing test is used mainly for billing purposes within the Mayo Clinic Laboratories to account for the identification of anaerobic organisms through genetic sequencing methods. This test reflects the financial transaction related to the identification process and does not form a part of direct clinical decision-making for the treatment of patients. It is not ordered in typical clinical workflow but may support billing for services provided internally.
Special Instructions
This test is exclusively for billing purposes and is not available for direct ordering by clinicians or external laboratories. It is not intended for use in clinical decision-making processes or as a standalone diagnostic tool. Laboratories using this test for billing should ensure appropriate internal coding and recognition of the service provided, as it reflects internal financial processes and lab resource utilization.
Limitations
The test is not applicable for direct clinical use and thus cannot provide genetic sequencing data or interpretive outcomes typically used in patient management. It serves no purpose for external practitioners or in decision-making for patient care. Since it is not orderable outside the billing context, there would be no practical application in diagnosing or guiding therapeutic strategies based on this test alone. Furthermore, any interpretation of genetic data or results is not included as part of this billing identifier and should be managed through separate analytic processes.
New York Approved
Methodology
Other
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided